Biotech · Private company
Neurogastrx, Inc.
Track this companyFree. Adds Neurogastrx, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- NG101Phase 2 · Diabetic GastroparesisClinicalTrials.gov · fetched Nov 12, 2026
- NG101Phase 2 · Overweight and ObesityClinicalTrials.gov · fetched Nov 12, 2026
- Semaglutide Injectable ProductPhase 2 · Overweight and ObesityClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) AgonistPHASE2 · COMPLETED · started Jun 24, 2024ClinicalTrials.gov NCT06500429 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic GastroparesisPHASE2 · COMPLETED · started Aug 1, 2020ClinicalTrials.gov NCT04303195 · fetched Nov 12, 2026